Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders

Andrzej Kokoszka

Abstract

7/2005 vol. 8

Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders

Andrzej Kokoszka

Przew Lek 2005, 7: 74-80

Online publish date: 2005/10/13

View full text

AMA

Kokoszka A. Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders. Przewodnik Lekarza/Guide for GPs. 2005:74-80.

APA

Kokoszka, A. (2005). Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders. Przewodnik Lekarza/Guide for GPs, 74-80.

Chicago

Kokoszka, Andrzej. 2005. "Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders". Przewodnik Lekarza/Guide for GPs: 74-80.

Harvard

Kokoszka, A. (2005). Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders. Przewodnik Lekarza/Guide for GPs, pp.74-80.

MLA

Kokoszka, Andrzej. "Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders." Przewodnik Lekarza/Guide for GPs, 2005, pp. 74-80.

Vancouver

Kokoszka A. Clinical usefulness of venlafaxine in the context of common comorbidities of depression and neurotic disorders. Przewodnik Lekarza/Guide for GPs. 2005:74-80.

The concise review of literature on venlafaxine, comorbidities of depression and neurotic disorders as well as application of venlafaxine in the treatment of other disorders, than depression is presented. The generalized anxiety disorder and social phobia, i. e., the most often comorbidies of depression, that can be trea-
ted with venlafaxine, are described.

Keywords

depression, neurotic disorders, comorbidity, venlafaxine

Integrated with